Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983;16(Suppl 2):231S–244S. doi: 10.1111/j.1365-2125.1983.tb02295.x

Chemical structure and biological activity of the diazepines

P Danneberg, K H Weber
PMCID: PMC1428206  PMID: 6140944

Abstract

1 Since the introduction of chlordiazepoxide and diazepam many diazepines have been developed. Use of these drugs is increasing and considerable knowledge has accumulated about their mechanisms of action.

2 The structural and pharmacological properties of these drugs are surveyed briefly.

Keywords: diazepines, biological activity, chemical structure

Full text

PDF
231S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battersby M. K., Richards J. G., Möhler H. Benzodiazepine receptor: photoaffinity labeling and localization. Eur J Pharmacol. 1979 Aug 1;57(2-3):277–278. doi: 10.1016/0014-2999(79)90379-0. [DOI] [PubMed] [Google Scholar]
  2. Beleslin D., Polak R. L., Sproull D. H. The effect of leptazol and strychnine on the acetylcholine release from the cat brain. J Physiol. 1965 Nov;181(2):308–316. doi: 10.1113/jphysiol.1965.sp007762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bergamaschi M., Longoni A. M. Cardiovascular events in anxiety: experimental studies in the conscious dog. Am Heart J. 1973 Sep;86(3):385–394. doi: 10.1016/0002-8703(73)90048-3. [DOI] [PubMed] [Google Scholar]
  4. Biggio G., Corda M. G., De Montis G., Stefanini E., Gessa G. L. Kainic acid differentiates GABA receptors from benzodiazepine receptors in the rat cerebellum. Brain Res. 1980 Jul 14;193(2):589–593. doi: 10.1016/0006-8993(80)90195-x. [DOI] [PubMed] [Google Scholar]
  5. Blanchard J. C., Boireau A., Garret C., Julou L. In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors. Life Sci. 1979 Jun 25;24(26):2417–2420. doi: 10.1016/0024-3205(79)90449-1. [DOI] [PubMed] [Google Scholar]
  6. Braestrup C., Squires R. F. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3805–3809. doi: 10.1073/pnas.74.9.3805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chou D. T., Wang S. C. Unit activity of amygdala and hippocampal neurons: effects of morphine and benzodiazepines. Brain Res. 1977 May 13;126(3):427–440. doi: 10.1016/0006-8993(77)90595-9. [DOI] [PubMed] [Google Scholar]
  8. Curtis D. R., Game C. J., Lodge D. Benzodiazepines and central glycine receptors. Br J Pharmacol. 1976 Mar;56(3):307–311. doi: 10.1111/j.1476-5381.1976.tb07643.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Davies L. P., Cook A. F., Poonian M., Taylor K. M. Displacement of [3H] diazepam binding in rat brain by dipyridamole and by 1-methylisoguanosine, a marine natural product with muscle relaxant activity. Life Sci. 1980 Mar 31;26(13):1089–1095. doi: 10.1016/0024-3205(80)90255-6. [DOI] [PubMed] [Google Scholar]
  10. Essman W. B. Benzodiazepines and aggressive behavior. Mod Probl Pharmacopsychiatry. 1978;13:13–28. doi: 10.1159/000401048. [DOI] [PubMed] [Google Scholar]
  11. Gallager D. W. Benzodiazepines: potentiation of a GABA inhibitory response in the dorsal raphe nucleus. Eur J Pharmacol. 1978 May 15;49(2):133–143. doi: 10.1016/0014-2999(78)90069-9. [DOI] [PubMed] [Google Scholar]
  12. Geller H. M., Woodward D. J. Synaptic organization of tuberal hypothalamus in tissue culture: effects of electrical stimulation and blockers of synaptic transmission. Exp Neurol. 1979 Jun;64(3):535–552. doi: 10.1016/0014-4886(79)90230-9. [DOI] [PubMed] [Google Scholar]
  13. Goldberg M. E., Manian A. A., Efron D. H. A comparative study of certain pharmacologic responses following acute and chronic administrations of chlordiazepoxide. Life Sci. 1967 Mar 1;6(5):481–491. doi: 10.1016/0024-3205(67)90051-3. [DOI] [PubMed] [Google Scholar]
  14. Grandison L., Guidotti A. Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology. 1977 Jul-Aug;16(7-8):533–536. doi: 10.1016/0028-3908(77)90019-3. [DOI] [PubMed] [Google Scholar]
  15. Haefely W., Ruch-Monachon M. A., Jalfre M., Schaffner R. Interaction of psychotropic agents with central neurotransmitters as revealed by their effects on PGO waves in the cat. Arzneimittelforschung. 1976;26(6):1036–1039. [PubMed] [Google Scholar]
  16. Hemsworth B. A., Neal M. J. The effect of central stimulant drugs on acetylcholine release from rat cerebral cortex. Br J Pharmacol. 1968 Nov;34(3):543–550. doi: 10.1111/j.1476-5381.1968.tb08483.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hunkeler W., Möhler H., Pieri L., Polc P., Bonetti E. P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature. 1981 Apr 9;290(5806):514–516. doi: 10.1038/290514a0. [DOI] [PubMed] [Google Scholar]
  18. Hunt P., Raynaud J. P. Benzodiazepine activity: is interaction with the glycine receptor, as evidenced by displacement of strychnine binding, a useful criterion? J Pharm Pharmacol. 1977 Jul;29(7):442–444. doi: 10.1111/j.2042-7158.1977.tb11363.x. [DOI] [PubMed] [Google Scholar]
  19. Kelly J., Grossman S. P. GABA and hypothalamic feeding systems. II. A comparison of GABA, glycine and actylcholine agonists and their antagonists. Pharmacol Biochem Behav. 1979 Dec;11(6):647–652. doi: 10.1016/0091-3057(79)90257-0. [DOI] [PubMed] [Google Scholar]
  20. Klepner C. A., Lippa A. S., Benson D. I., Sano M. C., Beer B. Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav. 1979 Oct;11(4):457–462. doi: 10.1016/0091-3057(79)90125-4. [DOI] [PubMed] [Google Scholar]
  21. Lidbrink P., Farnebo L. O. Uptake and release of noradrenaline in rat cerebral cortex in vitro: no effect of benzodiazepines and barbiturates. Neuropharmacology. 1973 Nov;12(11):1087–1095. doi: 10.1016/0028-3908(73)90053-1. [DOI] [PubMed] [Google Scholar]
  22. Lipp J. A. Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch Int Pharmacodyn Ther. 1973 Apr;202(2):244–251. [PubMed] [Google Scholar]
  23. Lippa A. S., Coupet J., Greenblatt E. N., Klepner C. A., Beer B. A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety. Pharmacol Biochem Behav. 1979 Jul;11(1):99–106. doi: 10.1016/0091-3057(79)90304-6. [DOI] [PubMed] [Google Scholar]
  24. Lippa A. S., Regan B. Additional studies on the importance of glycine and GABA in mediating the actions of benzodiazepines. Life Sci. 1977 Dec 15;21(12):1779–1783. doi: 10.1016/0024-3205(77)90158-8. [DOI] [PubMed] [Google Scholar]
  25. Locatelli V., Cocchi D., Frigerio C., Betti R., Krogsgaard-Larsen P., Racagni G., Müller E. E. Dual gamma-aminobutyric acid control of prolactin secretion in the rat. Endocrinology. 1979 Sep;105(3):778–785. doi: 10.1210/endo-105-3-778. [DOI] [PubMed] [Google Scholar]
  26. Margules D. L., Stein L. Increase of "antianxiety" activity and tolerance of behavioral depression during chronic administration of oxazepam. Psychopharmacologia. 1968;13(1):74–80. doi: 10.1007/BF00401620. [DOI] [PubMed] [Google Scholar]
  27. Montarolo P. G., Raschi F., Strata P. Interactions between benzodiazepines and GABA in the cerebellar cortex. Brain Res. 1979 Feb 23;162(2):358–362. doi: 10.1016/0006-8993(79)90298-1. [DOI] [PubMed] [Google Scholar]
  28. Möhler H., Battersby M. K., Richards J. G. Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1666–1670. doi: 10.1073/pnas.77.3.1666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Möhler H., Okada T. Benzodiazepine receptor: demonstration in the central nervous system. Science. 1977 Nov 25;198(4319):849–851. doi: 10.1126/science.918669. [DOI] [PubMed] [Google Scholar]
  30. Möhler H., Polc P., Cumin R., Pieri L., Kettler R. Nicotinamide is a brain constituent with benzodiazepine-like actions. Nature. 1979 Apr 5;278(5704):563–565. doi: 10.1038/278563a0. [DOI] [PubMed] [Google Scholar]
  31. Nielsen M., Braestrup C. Ethyl beta-carboline-3-carboxylate shows differential benzodiazepine receptor interaction. Nature. 1980 Aug 7;286(5773):606–607. doi: 10.1038/286606a0. [DOI] [PubMed] [Google Scholar]
  32. Ninan P. T., Insel T. M., Cohen R. M., Cook J. M., Skolnick P., Paul S. M. Benzodiazepine receptor-mediated experimental "anxiety" in primates. Science. 1982 Dec 24;218(4579):1332–1334. doi: 10.1126/science.6293059. [DOI] [PubMed] [Google Scholar]
  33. Olgiati V. R., Netti C., Guidobono F., Pecile A. The central GABAergic system and control of food intake under different experimental conditions. Psychopharmacology (Berl) 1980;68(2):163–167. doi: 10.1007/BF00432135. [DOI] [PubMed] [Google Scholar]
  34. Polc P., Haefely W. Effects of two benzodiazepines, phenobarbitone, and baclofen on synaptic transmission in the cat cuneate nucleus. Naunyn Schmiedebergs Arch Pharmacol. 1976 Aug;294(2):121–131. doi: 10.1007/BF00507844. [DOI] [PubMed] [Google Scholar]
  35. Polc P., Laurent J. P., Scherschlicht R., Haefely W. Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788. Naunyn Schmiedebergs Arch Pharmacol. 1981 Jul;316(4):317–325. doi: 10.1007/BF00501364. [DOI] [PubMed] [Google Scholar]
  36. Polc P., Möhler H., Haefely W. The effect of diazepam on spinal cord activities: possible sites and mechanisms of action. Naunyn Schmiedebergs Arch Pharmacol. 1974;284(4):319–337. doi: 10.1007/BF00504702. [DOI] [PubMed] [Google Scholar]
  37. Pozenel H., Bückert A., Amrein R. The antihypertensive effect of lexotan (bromazepam)- a new benzodiazepine derivative. Int J Clin Pharmacol Biopharm. 1977 Jan;15(1):31–39. [PubMed] [Google Scholar]
  38. Przybyla A. C., Wang S. C. Locus of central depressant action of diazepam. J Pharmacol Exp Ther. 1968 Oct;163(2):439–447. [PubMed] [Google Scholar]
  39. RANDALL L. O., SCHALLEK W., HEISE G. A., KEITH E. F., BAGDON R. E. The psychosedative properties of methaminodiazepoxide. J Pharmacol Exp Ther. 1960 Jun;129:163–171. [PubMed] [Google Scholar]
  40. Raabe W., Gumnit R. J. Anticonvulsant action of diazepam: increase of cortical postsynaptic inhibition. Epilepsia. 1977 Mar;18(1):117–120. doi: 10.1111/j.1528-1157.1977.tb05594.x. [DOI] [PubMed] [Google Scholar]
  41. Rump S., Grudzinska E., Edelwejn Z. Effects of diazepam on epileptiform patterns of bioelectrical activity of the rabbit's brain induced by fluostigmine. Neuropharmacology. 1973 Aug;12(8):813–817. doi: 10.1016/0028-3908(73)90022-1. [DOI] [PubMed] [Google Scholar]
  42. SCHALLEK W., KUEHN A. Effects of psychotropic drugs on limbic system of cat. Proc Soc Exp Biol Med. 1960 Oct;105:115–117. doi: 10.3181/00379727-105-26028. [DOI] [PubMed] [Google Scholar]
  43. Saner A., Pletscher A. Effect of diazepam on cerebral 5-hydroxytryptamine synthesis. Eur J Pharmacol. 1979 May 1;55(3):315–318. doi: 10.1016/0014-2999(79)90200-0. [DOI] [PubMed] [Google Scholar]
  44. Schmidt R. F., Vogel M. E., Zimmermann M. Die Wirkung von Diazepam auf die präsynaptische Hemmung und andere Rückenmarksreflexe. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;258(1):69–82. [PubMed] [Google Scholar]
  45. Skolnick P., Marangos P. J., Syapin P., Goodwin F. K., Paul S. M. CNS benzodiazepine receptors: physiological studies and putative endogenous ligands. Pharmacol Biochem Behav. 1979 May;10(5):815–823. doi: 10.1016/0091-3057(79)90340-x. [DOI] [PubMed] [Google Scholar]
  46. Snyder S. H., Enna S. J. The role of central glycine receptors in the pharmacologic actions of benzodiazepines. Adv Biochem Psychopharmacol. 1975;(14):81–91. [PubMed] [Google Scholar]
  47. Soubrié P., Thiébot M. H., Simon P., Boissier J. R. Benzodiazepines and behavioral effects of reward (water) omission in the rat. Psychopharmacology (Berl) 1978 Sep 15;59(1):95–100. doi: 10.1007/BF00428038. [DOI] [PubMed] [Google Scholar]
  48. Stein L., Wise C. D., Belluzzi J. D. Effects of benzodiazepines on central serotonergic mechanisms. Adv Biochem Psychopharmacol. 1975;(14):29–44. [PubMed] [Google Scholar]
  49. Tseng T. C., Wang S. C. Locus of action of centrally acting muscle relaxants, diazepam and tybamate. J Pharmacol Exp Ther. 1971 Aug;178(2):350–360. [PubMed] [Google Scholar]
  50. Valzelli L. Effect of sedatives and anxiolytics on aggressivity. Mod Probl Pharmacopsychiatry. 1979;14:143–156. doi: 10.1159/000401210. [DOI] [PubMed] [Google Scholar]
  51. Wolf P., Haas H. L. Effects of diazepines and barbiturates on hippocampal recurrent inhibition. Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;299(3):211–218. doi: 10.1007/BF00500313. [DOI] [PubMed] [Google Scholar]
  52. Yanagita T., Takahashi S. Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther. 1973 May;185(2):307–316. [PubMed] [Google Scholar]
  53. Young A. B., Snyder S. H. Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2832–2836. doi: 10.1073/pnas.70.10.2832. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES